AIM
BEAT

Arcadia Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Arcadia Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800
Closed -$36K – 287
2020
Q2 		$36K Hold
800
– – 0.01% 204
2020
Q1 		$31K Hold
800
– – 0.01% 216
2019
Q4 		$37K Hold
800
– – 0.01% 217
2019
Q3 		$33K Buy
800
+200
+33% +$8.63K 0.01% 229
2019
Q2 		$29K Buy
+600
New +$31.5K 0.01% 239

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Arcadia Investment Management's BEAT Position: Q3 2020 in Review

Arcadia Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 800 shares — an estimated $36K sold.

Arcadia Investment Management first reported a position in BEAT in Q2 2019 and held it in 5 quarters. The position peaked at $37K in Q4 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Arcadia Investment Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Arcadia Investment Management sold 800 BioTelemetry, Inc. shares in Q3 2020, an estimated $36K.
  • Arcadia Investment Management first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 5 quarters.
  • Arcadia Investment Management's BioTelemetry, Inc. position peaked at $37K in Q4 2019.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Arcadia Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.